Form 4 for AVXL ANAVEX LIFE SCIENCES CORP.
Accepted 2021-07-01 00:00:00 ET · period of report 2021-06-29 · accession 0001731122-21-001126 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-01 | 2021-06-29 | AVXL | Boenisch Sandra | PFO, Treas | S - Sale+OE | $26.53 | -166.7K | 23.0K | -88% | -$4.42M |
| DM | 2021-07-01 | 2021-06-29 | AVXL | Boenisch Sandra | PFO, Treas | M - OptEx | $4.19 | +166.7K | 48.0K | New | +$699.2K |
| DM | 2021-07-01 | 2021-06-29 | AVXL | Boenisch Sandra | PFO, Treas | M - OptEx | $0.00 | -166.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-06-29 | S | D | 166,696 | $26.53 | 22,963 | D | — | — | |
| 2 | Common | Common Stock | 2021-06-29 | M | A | 35,000 | $5.92 | 189,659 | D | — | — | |
| 3 | Common | Common Stock | 2021-06-29 | M | A | 106,696 | $3.28 | 154,659 | D | — | — | |
| 4 | Common | Common Stock | 2021-06-29 | M | A | 25,000 | $5.68 | 47,963 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-06-29 | M | D | 106,696 | $0.00 | 0 | D | $3.28 · 2016-09-22 to 2026-09-22 | 106,696 Common Stock | |
| 6 | Derivative | Stock Option (Right to Buy) | 2021-06-29 | M | D | 35,000 | $0.00 | 0 | D | $5.92 · — to 2027-05-12 | 35,000 Common Stock | (F2) The options subject to this grant vested quarterly over a three-year period commencing on June 30, 2017. |
| 7 | Derivative | Stock Option (Right to Buy) | 2021-06-29 | M | D | 25,000 | $0.00 | 0 | D | $5.68 · — to 2025-10-02 | 25,000 Common Stock | (F1) The options subject to this grant vested quarterly over a three-year period commencing on December 31, 2015. |